Top Authors

• Most frequent coverage on ALTH

• 
  Mike Havrilla (1932 followers)

  • Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities (Wed, Sep 30)
  • BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences (Fri, Sep 25)
  • FDA Calendar: 2H09 Binary Event Trades (Mon, Jul 27)

  More by Mike Havrilla on ALTH »
• 
  SA Editor Miriam Metzinger (539 followers)

  • Cramer's Lightning Round - What the Heck Is Going On with Apple? (12/7/09) (Tue, Dec 8)
  • Cramer's Mad Money - Oh, I'm a Lumberjack, Plum Creek's Okay (12/4/09) (Sun, Dec 6)
  • Cramer's Stop Trading! Why Is Boeing Flying? (11/16/09) (Tue, Nov 17)

  More by SA Editor Miriam Metzinger on ALTH »
• 
  Frederic Ruffy (600 followers)

  • Friday Options Recap (Fri, Aug 28)
  • Monday Options Recap (Mon, Jul 20)
  • Wednesday's Options Recap (Wed, Jun 10)

  More by Frederic Ruffy on ALTH »

• Most followed authors on ALTH

• 
  Mike Havrilla (1932 followers)

  • Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities (Wed, Sep 30)
  • BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences (Fri, Sep 25)
  • FDA Calendar: 2H09 Binary Event Trades (Mon, Jul 27)

  More by Mike Havrilla on ALTH »
• 
  Andrew Wilkinson (1161 followers)

  • Wednesday Options Update: ERTS, MSFT, ALTH & MT (Wed, Sep 23)
  • Tuesday Options Update: GLD, LEA, ALTH, MS, FXI, XHB, EEM, BNI (Tue, Jun 9)

  More by Andrew Wilkinson on ALTH »
• 
  J Clinton Hill (977 followers)

  • 20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week (Mon, Mar 2)

  More by J Clinton Hill on ALTH »

• Newest authors on ALTH

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • Five Drug Makers with Pending Catalysts (Tue, Sep 1)

  More by Justin M. Hall on ALTH »
• 
  Prohost Biotech (90 followers)

  • Will the FDA Approve Allos Therapeutics' New Cancer Drug? (Fri, Sep 4)

  More by Prohost Biotech on ALTH »
• 
  M. E. Garza (520 followers)

  • Movers and Shakers Include Flu Stocks Sinovac and BioCryst Pharma (Wed, Oct 14)
  • Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy (Fri, Sep 4)

  More by M. E. Garza on ALTH »

• Most commented on ALTH

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • Five Drug Makers with Pending Catalysts (Tue, Sep 1)

  More by Justin M. Hall on ALTH »
• 
  Andrew Mickey (862 followers)

  • Where the Big Money Is Betting Big (Fri, May 15)

  More by Andrew Mickey on ALTH »
• 
  SA Editor Miriam Metzinger (539 followers)

  • Cramer's Lightning Round - What the Heck Is Going On with Apple? (12/7/09) (Tue, Dec 8)
  • Cramer's Mad Money - Oh, I'm a Lumberjack, Plum Creek's Okay (12/4/09) (Sun, Dec 6)
  • Cramer's Stop Trading! Why Is Boeing Flying? (11/16/09) (Tue, Nov 17)

  More by SA Editor Miriam Metzinger on ALTH »